# A Two-part Proof-of-Concept Study Assessing the Safety and Efficacy of LAT8881 in Lumbar Radicular Pain

> **NCT05298306** · PHASE1 · COMPLETED · sponsor: **Lateral Pharma Pty Ltd** · enrollment: 26 (actual)

## Conditions studied

- Radiculopathy Lumbar

## Interventions

- **DRUG:** LAT8881
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05298306
- **Lead sponsor:** Lateral Pharma Pty Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-05-17
- **Primary completion:** 2023-05-12
- **Final completion:** 2023-06-16
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2024-11-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05298306

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05298306, "A Two-part Proof-of-Concept Study Assessing the Safety and Efficacy of LAT8881 in Lumbar Radicular Pain". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05298306. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*